Table 2. Association of tertiles of biomarker of soy intake (24UI) with cardiovascular risks, fasting blood, and 24U in Japanese, Hyogo inhabitants aged 30 to 79 Years.
| Tertile of 24UI/Creatinine ratio, mmol/mmol | P for linear trend1 | |||
|---|---|---|---|---|
| 1 (low) | 2 | 3 (high) | ||
| Median | 0.3 | 1.1 | 3.6 | |
| Range | 0.0–0.6 | 0.6–1.9 | 2.0–15.6 | |
| Body mass Index | ||||
| n | 100 | 102 | 101 | |
| Crude | 22.4 ± 0.32 | 22.8 ± 0.3 | 22.2 ± 0.3 | NS |
| Age and gender adjusted | 22.4 ± 0.3 | 22.8 ± 0.3 | 22.2 ± 0.3 | NS |
| Systolic blood pressure (mmHg) | ||||
| n | 100 | 102 | 101 | |
| Crude | 121.9 ± 1.6 | 122.1 ± 1.8 | 123.9 ± 1.6 | NS |
| Age and gender adjusted | 123.2 ± 1.6 | 122.6 ± 1.5 | 121.9 ± 1.6 | NS |
| Diastolic blood pressure (mmHg) | ||||
| n | 100 | 102 | 101 | |
| Crude | 73.5 ± 1.2 | 73.9 ± 1.2 | 72.4 ± 1.1 | NS |
| Age and gender adjusted | 73.1 ± 1.2 | 74.1 ± 1.1 | 72.6 ± 1.2 | NS |
| Serum total cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 202.7 ± 3.4 | 201.5 ± 3.4 | 216.0 ± 3.6 | p<0.01 |
| Age and gender adjusted | 208.5 ± 3.4 | 202.5 ± 3.3 | 209.2 ± 3.4 | NS |
| Low-density lipoprotein cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 120.6 ± 3.2 | 119.6 ± 3.1 | 129.3 ± 3.3 | p<0.05 |
| Age and gender adjusted | 125.7 ± 3.1 | 120.6 ± 3.0 | 123.2 ± 3.1 | NS |
| High-density lipoprotein cholesterol (mg/dL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 61.9 ± 1.4 | 62.2 ± 1.6 | 65.0 ± 1.4 | NS |
| Age and gender adjusted | 62.4 ± 1.5 | 62.0 ± 1.4 | 64.8 ± 1.5 | NS |
| Triglyceride (mg/dL) | ||||
| n | 95 | 100 | 97 | |
| Crude | 104.2 ± 6.8 | 105.2 ± 7.3 | 108.3 ± 7.4 | NS |
| Age and gender adjusted | 102.9 ± 7.3 | 106.0 ± 6.9 | 108.7 ± 7.4 | NS |
| Folate (ng/mL) | ||||
| n | 100 | 102 | 101 | |
| Crude | 5.8 ± 0.3 | 6.4 ± 0.3 | 8.4 ± 0.4 | p<0.01 |
| Age and gender adjusted | 6.0 ± 0.3 | 6.4 ± 0.3 | 8.1 ± 0.3 | p<0.01 |
| 24U Salt (g/day) | ||||
| n | 100 | 102 | 101 | |
| Crude | 10.5 ± 0.4 | 11.5 ± 0.4 | 11.6 ± 0.5 | NS |
| Age and gender adjusted | 9.9 ± 0.5 | 11.4 ± 0.4 | 12.3 ± 0.5 | p<0.001 |
| 24U potassium (g/day) | ||||
| n | 100 | 102 | 101 | |
| Crude | 1.7 ± 0.1 | 1.9 ± 0.1 | 2.4 ± 0.1 | p<0.001 |
| Age and gender adjusted | 1.7 ± 0.1 | 1.9 ± 0.1 | 2.3 ± 0.1 | p<0.001 |
| Sodium/potassium ratio (mEq/mEq) | ||||
| n | 100 | 102 | 101 | |
| Crude | 4.5 ± 0.2 | 4.3 ± 0.2 | 3.5 ± 0.2 | p<0.001 |
| Age and gender adjusted | 4.2 ± 0.2 | 4.2 ± 0.2 | 3.8 ± 0.2 | NS |
Abbreviations: n, number; 24U, 24-hour urine; 24UI, 24-hour urinary isoflavones.
1 From multiple linear regression models for the relationship between 24UI/creatinine ratio and cardiovascular risks, fasting blood, and 24U.
2Mean ± standard error (SE) (all such values).